MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
OBSV - ObsEva SA.
$3.89
-0.39(-9.11%)9:00:00 PM 2/25/2021
ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
MarketCap186.5M
PE Ratio
PEG Ratio
P/B9.6
P/S (ttm)14762.9
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %3%
Held by Institutions %48%
1 Day Vol Adjusted Return-1.1
1 Month Vol Adjusted Return0.3
3 Month Vol Adjusted Return10.2
6 Month Vol Adjusted Return4.5
20 Days SMA Price ZScore-0.4
50 Days SMA Price ZScore0.7
12 -26 Days PPO7.2
1 Month Average Short Volume Ratio26.2
1 Day Volume Change ZScore-0.1
1 Month Daily Vol8.4
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news

    02/18/2021OBSV
    2 “Strong Buy” Penny Stocks That Could Rally Over 100%

    Bank of America has a strong reputation for keeping finger on the pulse of the financial world – and one of its key tools is the Global Fund Manager Survey, conducted monthly and seeking opinions from more than 200 hedge fund, mutual fund, and pension fund managers who hold a combined $645 billion in AUM. It’s the largest regularly conducted survey of its kind. And BofA most recent findings show that Big Money is feeling confident. More than 90% of investors surveyed believe that 2021 will show ...

    02/17/2021OBSV
    ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference

    Geneva, Switzerland and Boston, MA – February 17, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that Company Management will be participating in a fireside chat and one-on-one investor meetings at the SVB Leerink 10th Annual Global Healthcare Conference. Details on the presentation can be found below. Date: Wednesday, February 24, 2021 Time:8:40 AM ET W...

    02/15/2021OBSV
    ObsEva SA (NASDAQ:OBSV) Shares Could Be 46% Below Their Intrinsic Value Estimate

    How far off is ObsEva SA ( NASDAQ:OBSV ) from its intrinsic value? Using the most recent financial data, we'll take a...

    02/11/2021OBSV
    ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares

    Geneva, Switzerland and Boston, MA – Thursday 11 February, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, announced today that its board of directors approved on February 10, 2021 an increase of its share capital from 69,629,347 to 81,220,471 through the issue of 11,591,124 new registered shares a...

    02/10/2021OBSV
    ObsEva Provides Business Outlook for 2021

    GENEVA, Switzerland and BOSTON, MA (February 10, 2021) – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today provided a corporate update, including its roadmap for advancing its clinical programs in 2021. “We made significant progress across all aspects of the company in 2020, most significantly preparing Yselty® for uterine fibroids for regulatory approval with a filed and validated Europea...

    01/28/2021OBSV
    ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares

    Geneva, Switzerland and Boston, MA – Thursday 28 January, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, announced today that its board of directors approved on January 27, 2021 an increase of its share capital from 60,202,619 to 66,222,867 through the issuance of 6,020,248 new registered shares a...

    01/21/2021OBSV
    01/19/2021OBSV
    Implied Volatility Surging for ObsEva (OBSV) Stock Options

    Investors need to pay close attention to ObsEva (OBSV) stock based on the movements in the options market lately.

    01/15/2021OBSV
    OBSV Stock: 7 Things for ObsEva Investors to Know Before Investing in the Penny Stock

    ObsEva (NASDAQ:OBSV) stock is soaring higher on Friday despite there not being any noteworthy news today. Source: Bukhta Yurii / Shutterstock.com To go along with the increase in price, shares of OBSV stock are also experiencing heavy trading today. That’s resulted in more than 79 million shares of the stock trading as of this writing. That’s a massive spike over the company’s daily average trading volume of 1.2 million shares. So why exactly are shares of OBSV stock on the rise today? The only ...